DNAlogy MultiUrine Test is a new and advanced method for the simultaneous detection of 29 drug / pharmaceutical substances, and alcohol in urine samples. It is a highly sensitive technology that detects each substance quantitatively as well as its metabolites, while the test requires a very small amount of urine (only 400μl).

Detected substances:

The test detects 12 most currently abused drugs in human urine samples.

Detected substances:

The test detects 10 most currently abused drug and pharmaceutical substances in human urine samples.

Detected substances: 

The test detects tranquilizers, sedatives and sleeping pills in human urine samples. The test includes detection of barbiturates (BAR), benzodiazepines (BZD), tricyclic antidepressants (TCA) and zolpidem (ZOL).

The test detects alcohol use or abuse through the detection of ethyl glucuronide (EtG) in human urine samples. EtG is the main biomarker when it comes to highlight alcohol consumption, as this is a major metabolite of the ethanol contained in alcoholic beverages and can be detected up to 2-3 days after the last alcohol intake.  The urine test will be particularly useful in cases where alcohol consumption is absolutely prohibited, as in a medically supervised withdrawal, or in some professional environments that require total abstinence for safety reasons (e.g., in transport).

The test is semi-quantitative and detects THC (marijuana, cannabis) in human urine samples as well as the presence of any cannabinoid (Marijuana, hashish, Cannabis oil) whatever the mode of consumption (joints, inhaling, infusion, or culinary preparations like cakes) from 2 to 30 days after last intake. In the results, concentration of THC in urine is described as LOW, MEDIUM, or HIGH. This test is particularly effective over time. Initial screening will serve as a baseline, while the following tests are performed to determine the lowering or raising level of THC in urine samples. By practicing regular screenings, it is now much easier to see if a person has stopped consumption (steady decrease in the level of THC) or started over (sudden increase in the level of THC).

The test is semi-quantitative and detects nicotine use in human urine, which is found in cigarettes and other tobacco products. The test is based on the detection of cotinine, a molecule which is the main derivative of the nicotine after consumption, from 48 to 72 hours after last intake. In the results, concentration of cotinine in urine is described as LOW, MEDIUM, or HIGH, which corresponds to less than 3 cigarettes on the last 48 hours (1^st level of consumption), 3-10 cigarettes per day (2^nd level of consumption) or more than 10 cigarettes per day (3^rd level of consumption), respectively.